Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-059-9 | CAS number: 64741-58-8 A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C30 and boiling in the range of approximately 230°C to 450°C (446°F to 842°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restrictions because it is an acceptable and well-documented study report.
- Justification for type of information:
- This study is on a substance from a different IUCLID category. It is not intended to fill a data gap for the VHGO category, but it can provide useful supportive information and help to show that there is lower concern for other pools of constituents e.g. aliphatics (paraffinics and naphthenics) and mono- or di-aromatics within the category that may not be the main drivers of toxicity. Please see read-across document for more details.
All PS come from a single source of crude oil and the differences in properties and molecular pools is the result of downstream processing. Some streams have similar constituent pools and these can provide us with supporting evidence relevant to VHGO’s. For example, Kerosines (e.g. JP-8 jet fuel, CAS 8008-20-6) has a similar, but slightly shorter, carbon chain length profile but does not contain significant amounts of the PAH constituents considered to be the drivers of toxicological hazard for VHGO. The results of a 90-day oral toxicity studies can therefore inform us about the reproductive and systemic toxicity potential of pools of hydrocarbons present in all both categories but considered less hazardous than the worst-case PAH.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Principles of method if other than guideline:
- This was a reproductive study performed in two parts. Haematology, clinical chemistry, and histopathology in males were reported in Mattie et al. 1995 and were not repeated as part of this study design. In the first part, males were treated for 70 to 90 days with 0 (1mL of distilled water), 750, 1500, or 3000 mg/kg/day of undiluted JP-8 jet fuel, then mated to untreated females (one female at a time). In the second part of the study, female rats were administered the test compound at doses of 0 (1mL of distilled water), 375, 750, or 1500 mg/kg/day undiluted JP-8 jet fuel for 90 -day prior to mating, through mating, gestation, delivery, and lactation for a total of 21 weeks.
- GLP compliance:
- yes
Test material
- Reference substance name:
- most likely 8008-20-6
- IUPAC Name:
- most likely 8008-20-6
- Reference substance name:
- JP-8 jet fuel
- IUPAC Name:
- JP-8 jet fuel
- Test material form:
- other: low viscosity liquid hydrocarbon
- Details on test material:
- - Name of test material (as cited in study report): JP-8 jet fuel
- Other: The fuel met the requirements of Military Specification MIL-T-83133A.
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Labs, Kingston, New York
- Weight at study initiation: 180 to 220 grams
- Housing: Individually, except during cohabitation (1 male with 1 female)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: Not reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 to 25 °C
- Humidity (%): Not reported
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12 hours dark/12 hours light
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Duration of treatment / exposure:
- Males were treated for 70 to 90 days. Females were treated for 21 weeks.
- Frequency of treatment:
- Daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
Males: 750, 1500, or 3000 mg/kg/day
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
Females: 325, 750, or 1500 mg/kg/day
Basis:
actual ingested
- No. of animals per sex per dose:
- A minimum of 20 male rats per dose were used to test male fertility and a minimum of 35 female rats were used to test effects on female fertility.
- Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: Doses were based on a previous 90-day study.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Not reported
- Cage side observations examined were not reported.
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations:Daily
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: At study termination
- Anaesthetic used for blood collection: No
- Animals fasted: No data
- How many animals: A maximum of 10 females per treatment group
- Parameters checked in table 1 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: At study termination
- Animals fasted: No data
- How many animals: A maximum of 10 females per treatment group
- Parameters checked in table 2 were examined.
URINALYSIS: Yes
- Time schedule for collection of urine: At weaning, 24 hours prior to sacrifice
- Metabolism cages used for collection of urine: Yes
- Animals fasted: No data
- Parameters checked in table 3 were examined.
NEUROBEHAVIOURAL EXAMINATION: No
OTHER: Males: fertility and sperm analysis; Females: in the same rats used for haematology and clinical chemistry, the brain, kidneys, liver, spleen, and ovaries were weighed; reproduction indices - Sacrifice and pathology:
- GROSS PATHOLOGY: No data
HISTOPATHOLOGY: Yes (see table 4) - Other examinations:
- Fertility parameters were measured in both males and females.
- Statistics:
- General toxicity data: an ANOVA with or without multiple comparisons
Reproductive measures: a one- or two-factor ANOVA and a post-hoc comparison of dose using two-tailed t-test with pooled error was used for continuous data; a Chi-square test of proportions followed by a Fischer's Exact test was used for categorical data
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- CLINICAL SIGNS AND MORTALITY: There were no changes in clinical signs or mortality.
BODY WEIGHT AND WEIGHT GAIN: Body weights in male rats were decreased in a dose-dependent manner. Terminal body weights were approximately 545 grams, 520 grams, 475 grams, and 315 grams in the control, 750, 1500, and 3000 mg/kg/day, respectively (results were approximated from a figure). In females, body weight was only significantly reduced in the high-dose group, but the differences were not significant at terminal sacrifice. The body weight in females at 20 weeks (1 week before sacrifice) was approximately 400 grams, 385 grams, 382 grams, and 335 grams in the control, 375, 750, and 1500 mg/kg/day, respectively.
HAEMATOLOGY: Haematology was not measured in the males and no effects were noted in the females.
CLINICAL CHEMISTRY: Clinical chemistry was not measured in the males and no effects were noted in the females.
URINALYSIS: Urinalysis was not measured in the males and no effects were noted in the females.
ORGAN WEIGHTS: Absolute and relative liver weights were increased in mid- and high-dose females (Table 1).
HISTOPATHOLOGY: The test compound caused perianal dermatitis (high-dose only) and stomach hyperplasia (mid- and high-dose) in the female rats (Table 2).
OTHER FINDINGS: There were no treatment-related effects on reproduction or sperm parameters in males. There were no effects on reproduction, gestation, or litter size in females. There was a dose-related decrease in pup weight that was significant in the 750 mg/kg/day group on postnatal day 4 only and in the 1500 mg/kg/day group from postnatal day 4 through postnatal day 21 but had recovered by postnatal day 90.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 750 mg/kg bw/day (actual dose received)
- Sex:
- female
- Basis for effect level:
- other: body weight
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The decreased body weight in males was probably related to nephropathy that is typically produced in male rats exposed to hydrocarbon fuels. Although there were changes in liver weight in the females, this was not accompanied by any changes in clinical chemistry or liver histopathology so is likely not of biological significance.
Table 5
Body weight and liver weights in female rats |
||||
|
Control |
325 mg/kg/day |
750 mg/kg/day |
1500 mg/kg/day |
|
n=10 |
n=7 |
n=8 |
n=8 |
Terminal Body weight |
351.0 ± 12.6 |
354.3 ± 9.0 |
357.5 ± 6.5 |
348.8 ± 16.3 |
Absolute liver weight |
14.8 ± 0.8 |
15.7 ± 0.6 |
17.8 ± 0.7 * |
19.1 ± 0.7 ** |
Liver to body weight |
4.2 ± 0.1 |
4.4 ± 0.1 |
5.0 ± 0.2 ** |
5.5 ± 0.1 ** |
Liver to brain weight |
754.9 ±38.9 |
823.6 ± 39.8 |
903.1 ± 31.8 * |
993.6 ± 46.3 ** |
* p<0.05
** p<0.01
Table 6
Incidence and severity significant histopathological findings in female rats |
||||
|
Control |
325 mg/kg/day |
750 mg/kg/day |
1500 mg/kg/day |
|
n=8 |
n=4 |
n=5 |
n=6 |
Perianal dermatitis |
0 |
0 |
0 |
83% (1.2) * |
Anal hyperplasia |
0 |
0 |
0 |
50% (0.7) |
Stomach gastritis |
0 |
50% (0.5) |
20% (0.2) |
0 |
Stomach hyperplasia |
0 |
75% (0.8) |
100% (1.6) * |
100% (1.7) * |
* p<0.05
Applicant's summary and conclusion
- Conclusions:
- The study LOAEL for systemic effects is 1500 mg/kg/day and the NOAEL for systemic effects is 750 mg/kg/day, based on reduced body weight in dams and in pups. The LOAEL for adult males rats exposed to JP-8 orally was 750 mg/kg/day due to changes in clinical pathology, body weight, organ weights and the same irritation seen in female rats. The reproduction NOAEL was 3000 and 1500 mg/kg/day in males and females, respectively.
- Executive summary:
This was a reproductive study performed in two parts. In the first part, males were treated for 70 to 90 days with 0 (1mL of distilled water), 750, 1500, or 3000 mg/kg/day of undiluted JP-8 jet fuel, then mated to untreated females (one female at a time). Males were gavaged throughout the cohabitation period and were returned to their individual cage after successful mating. In the second part of the study, female rats were administered the test compound at doses of 0 (1mL of distilled water), 375, 750, or 1500 mg/kg/day undiluted JP-8 jet fuel for 90 -day prior to mating, through mating, gestation, delivery, and lactation for a total of 21 week. During mating, they were housed with untreated males. Litters were standardized to 4 male pups and 4 female pups on postnatal day 5. Although those pups were used for neurobehavioral tests, the data was not provided in the study report.
There were no effects on clinical signs or mortality in either sex. Haematology, clinical chemistry, and urinalysis were measured only in females without any effects noted. Body weights in male rats were decreased in a dose-dependent manner and was likely related to nephropathy that is specific in male rats treated with hydrocarbons. In females, body weight was only significantly reduced in the high-dose group. Absolute and relative liver weights were increased in mid- and high-dose females, but were not likely biologically significant due to the lack of changes in clinical chemistry or histopathology in the liver. The test compound caused perianal dermatitis (high-dose only) and stomach hyperplasia (mid- and high-dose) in the female rats (histopathology was not conducted on the males for this study because previous studies have indicated nephropathy). There were no treatment-related effects on reproduction or sperm parameters in males. There were no effects on reproduction, gestation, or litter size in females. There was a dose-related decrease in pup weight that was significant in the 750 mg/kg/day group on postnatal day 4 only and in the 1500 mg/kg/day group from postnatal day 4 through postnatal day 21 but had recovered by postnatal day 90.
The study LOAEL for systemic effects is 1500 mg/kg/day and the NOAEL for systemic effects is 750 mg/kg/day, based on reduced body weight in dams and in pups. The LOAEL for adult males rats exposed to JP-8 orally was 750 mg/kg/day due to changes in clinical pathology, body weight, organ weights and the same irritation seen in female rats.Changes in male rats may be complicated by the male rat-specific nephropathy produced after exposure to hydrocarbon fuels such as JP-4 and JP-8. The reproduction NOAEL was 3000 and 1500 mg/kg/day in males and females, respectively.
This study received a Klimisch score of 1 and is classified as reliable without restrictions because it is an acceptable and well-documented study report.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)